Envestnet Asset Management’s Usana Health Sciences USNA Stock Holding History

Envestnet Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-494	Closed	-$57K	–	2561
2018 Q2	$57K	Buy	494 +2	+0.4%	+$219	﹤0.01%	2169
2018 Q1	$42K	Sell	492 -46	-9%	-$3.56K	﹤0.01%	2194
2017 Q4	$40K	Sell	538 -73	-12%	-$4.88K	﹤0.01%	2372
2017 Q3	$36K	Sell	611 -62	-9%	-$3.66K	﹤0.01%	2367
2017 Q2	$43K	Sell	673 -26	-4%	-$1.6K	﹤0.01%	2410
2017 Q1	$41K	Sell	699 -27	-4%	-$1.61K	﹤0.01%	2484
2016 Q4	$45K	Buy	+726	New	+$47.3K	﹤0.01%	2478

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Envestnet Asset Management's USNA Position: Q3 2018 in Review

Envestnet Asset Management sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 494 shares — an estimated $57K sold.

Envestnet Asset Management first reported a position in USNA in Q4 2016 and held it in 7 quarters. The position peaked at $57K in Q2 2018. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

Envestnet Asset Management reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
Envestnet Asset Management sold 494 Usana Health Sciences shares in Q3 2018, an estimated $57K.
Envestnet Asset Management first reported a position in Usana Health Sciences in Q4 2016 and held it in 7 quarters.
Envestnet Asset Management's Usana Health Sciences position peaked at $57K in Q2 2018.
197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.